Breakthrough Technology Alert

This is the best time to be investing in world-changing technologies, as unprecedented innovations are taking off right now...

In Breakthrough Technology Alert, Ray Blanco tirelessly researches these exciting new breakthrough technologies and tells you exactly what you need to do to profit from them.

Alnylam, Provectus and Cellceutix News

I haven't written a lot about Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) lately, in large part because the company is so heavily invested in research, thanks to early enthusiasm over the potential of RNA interference. It's also the most visible of the RNAi companies, with a relatively large capitalization of more than half a billion dollars and a healthy trading volume. Traders have a large impact on this company's stock, and the ongoing sorting out of intellectual property rights has made the company impossible to predict.

You Must Be A Subscriber To View This Content.

If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!


Breakthrough Technology Alert

This is the best time to be investing in world-changing technologies, as unprecedented innovations are taking off right now… Breakthrough Technology Alert tirelessly researches these exciting new breakthrough technologies to keep you well informed, outline specific opportunities, and keep you ahead of the game.

LoginGet Access

Patrick Cox

Patrick Cox has lived deep inside transformative technologies for over 25 years. In the 1980s, he worked in software development and manufacturing. By the mid-‘90s, he consulted for Netscape–which handled 90% of all Internet browsing traffic at the time. InfoWorld and USA Today have featured his research, and he’s written for The Wall Street Journal,...

View More By Patrick Cox

LEARN TO TRADE LIKE A PRO WITH THE SEVEN FIGURE PODCAST! [CLICK HERE]